Formation of Pyrazol-1,3,4-Thiadiazoles through 1,3-Dipolar Cycloadditions of 3-Thioxo-[1,2,4]-Triazepin-5-one with Nitrilimines: An Experimental and Computational study by Esseffar, M. et al.
 1
Formation of Pyrazol-1,3,4-Thiadiazoles through 1,3-Dipolar  
Cycloadditions of 3-Thioxo-[1,2,4]-Triazepin-5-one with Nitrilimines: An  
Experimental and Computational study. 
 
M. Esseffar*a, M. El Messaoudia, S. Azzouzia, R. Jalalb, J. A. Sáezc, L. R. Domingo*c 
J. Latorre,d M. Liu-Gonzáleze 
 
a Université Cadi ayyad, Faculté des Sciences-Semlalia, Département de Chimie, B.P. 2390, Marrakech, Morocco. 
b Université Cadi ayyad, Faculté des Sciences et Techniques, Département des Sciences Chimique, B.P. 549, Marrakesh, 
Morocco.  
c Departamento de Química Orgánica, Universidad de Valencia, Dr. Moliner 50, 46100 Burjassot, Valencia, Spain. 
d Instituto de Ciencia de Materiales, Universidad de Valencia, Poligono la coma s/n, 46980 Paterna, Spain. 
e S.C.S.I.E (RX) Universidad de Valencia, Dr.  Moliner 50,Burjassot 46100, Spain. 
 
ABSTRACT 
In this work the results of experimental and computational study of the title compounds and 
some ancillary compounds are reported. Two bicyclic pyrazol-1,3,4-thiadiazole derivatives  
were synthesized by reaction between 6-dimethylaminomethylene-3-thioxo-[1,2,4]-
triazepin-5-one 1 and several nitrilimines 2a-f to give corresponding spirocycloadducts 3a-f, 
which undergo a rapid rearrangement leading to the new bicyclic compounds, 4a-f and 5a-f. 
These obtained bicyclic products were characterized by 1H and 13C NMR spectroscopy and 
finally by X-ray crystallography. Theoretical calculations have been carried out using DFT 
methods to rationalize the formation of the two new bicyclic compounds. Two reaction types 
are involved in the formation of the compounds 4a-f and 5a-f. The first one is a 1,3-dipolar 
cycloaddition reaction between 1 acting as dipolarophile and 2a-f as dipoles. The results 
indicate that the cycloaddition between 1 and 2g, as model of 2a-c, takes place via a high 
asynchronous bond-formation process. The regioselectivity obtained from the calculations is 
in complete agreement with the formation of the unique spirocycloadducts 3a-f. The second 
reaction leading to the formation of the final products is a domino process that is initiated by 
the quick and irreversible cleavage in a catalytic acid environment of triazepenic ring. 
 
 
¤dedicated to the memory of Tourya El Messaoudi 1975-2003.  
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INTRODUCTION 
Triazepine derivatives have attracted a great deal of attention because of their ability to 
act as anti-convulsant and anti-anxiety. Their oxo and thioxo derivatives have acquired both 
pharmaceutical and economical relevance.1 Triazepines and diazepines have attracted a great 
attention as starting materiel in the synthesis of fused heterocyclic systems of potential 
pharmacological activities.2-9 Different triazepine derivatives have exhibited significant 
biological activities.10-13 The area of biological interest of this family of compounds have 
been extended to various diseases such as cancer,7 viral infections (HIV)8 and cardiovascular 
disorders.9,10 It is known that the pharmacological activity appears to be enhanced when a 
further heterocyclic ring is linked to the heptatomic nucleus.14,15 They are reported as 
excellent ligands with transition metals inducing a large application in organometallic 
chemistry.16,17  
In the context of our current interest in the synthesis of novel heterocyclic 
compounds,18-22 susceptible to have biological activity, we have now studied the 1,3-dipolar 
cycloaddition (13DC) reaction between 6-dimethylaminomethylene-3-thioxo-[1,2,4]-
triazepin-5-one 1 and C,N-disubstituted nitrilimines 2a-f (Scheme 1), which were generated 
in situ from the appropriate precursors and triethylamine. However, we have found that 
along the purification of reaction mixture by column chromatography, the corresponding 
spirocycloadducts 3a-f were transformed into the bicyclic compounds 4a-f and 5a-f. Herein, 
we present the experimental results of the title reaction together with a theoretical study 
providing an explanation for the formation of the two new bicyclic compounds. Firstly, we 
describe the synthesis of the novel triazepine 1 and the 13DC reaction with the nitrilimines 
2a-f. Then, a theoretical study of the molecular mechanism of the chemical reactions 
experimentally observed is performed. 
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RESULTS AND DISCUSSION 
1. Experimental results.  
1.1. Synthesis of 3-thioxo-[1,2,4]-triazepin-5-one 1 
The 3-thioxo-[1,2,4]-triazepin-5-one 1 was obtained in good yield (70%) by stirring a 
mixture of [1,2,4]-triazepine 6 and dimethylformamide-dimethylacetal (DMF-DMA) during 
one hour at 5°C (see Scheme 2). 
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Scheme 2 
NMR spectra of the obtained product showed the presence of a mixture of two 
stereoisomers 1Z and 1E. The percentage of these stereoisomers was deduced by 1H NMR 
spectrum: 34% and 66% respectively. The structures of the two stereoisomers were assigned 
easily by NMR spectra and mass spectrum. In 1H NMR spectrum, the presence of the 
exocyclic double bond C=C is pointed out by two singlets at 7.05 and 7.55 ppm attributables 
respectively to ethylenic proton -C=CH of structures 1Z and 1E. This attribution of these 
values is supported by a simulation of 1H RMN chemical shifts related to ethylenic protons. 
The higher chemical shift of the ethylenic proton of 1E is due to the proton proximity to the 
carbonyl group. The 13C NMR spectrum of these stereoisomers is characterized mainly by 
the absence of resonance signal of methylene group in position 6 and by the presence of 
signal of carbon C6 at 96.5 for 1Z and 96.1 ppm for 1E. The chemical shifts at 154.5 for 1E 
and 154.1 ppm for 1Z attributed to the carbon of exocyclic double bond (-C=CH), permitted 
to confirm again the presence of this exocyclic double bond. The carbons of thioxo and oxo 
groups are also clearly identified in this spectrum (177.5 and 168.2 ppm for 1E and 177.2 
and 164.9 ppm for 1Z respectively). 
1.2. 1,3-Dipolar cycloaddition of 3-thioxo-[1,2,4]-triazepin-5-one 1 with N-aryl-C-
ethoxycarbonyl-nitrilimines and diarylnitrilimines 2a-f. 
Nitrilimines 2a-f were generated in situ by treating appropriate ethylhydrazono-α-
bromoglyoxylate for 2a-c and α-chloroarylidenephenylhydrazones for 2d-f with 
triethylamine. After treatment of the 3-thioxo-[1,2,4]triazepin-5-one 1 with nitrilimines 2a-c 
at room temperature over 72 hours, the spirocycloadducts 3a-c were isolated as a mixture of 
two stereoisomers 3E and 3Z in a ratio 7:3 (see Scheme 1 and Table 2). However, during the 
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separation of the reaction mixture on column chromatography, the cycloaducts were 
transformed to the bicyclo compounds 4a-c and 5a-c. In the case of the addition of 
nitrilimines 2d-f, the cycloadducts 3d-f were not isolated in spite of using all the necessary 
precautions. The unique isolated products are 4d-f and 5d-f. When thin-layer 
chromatography was performed and visualized under UV light, the 3d-f spot appears as the 
same time as 4d-f and 5d-f, but disappears very quickly during the purification. Probably, the 
attractor effect of CO2Et group presents in 2a-c make the cycloadducts 3a-c relatively more 
stable than 3d-f. On the other hand, it is known that this type of compounds is described as 
unstable products.23  
Table 1. Reaction of 3-thioxo-[1,2,4]-triazepin-5-one 1 with nitrilimines 2a-f. 
2 R1 R2  3  (E/Z)Percentage  Yield (%) Ratio (4:5)  
2a p-CH3C6H4 CO2Et 3a 68-32  67  55 : 45 
2b p-ClC6H4 CO2Et 3b 67-33  70 54 : 46 
2c p-NO2C6H4 CO2Et 3c 72-28  66 53 : 47 
2d C6H5 p-CH3C6H4 3d not isolated  48 54 : 46 
2e C6H5 p-ClC6H4 3e not isolated  48 56 : 44 
2f C6H5 p-NO2C6H4 3f not isolated   42 56 : 44 
 
Formation of the spirocycloadducts 3a-c was detected by NMR and mass spectra of 
their crude reaction. The orientation in the structures 3a-c and the active site of 1 were 
unequivocally determined on the basis of diagnostic 1H and 13C NMR data. This result was 
confirmed also by X-ray diffraction analysis of 4d and 5e compounds (Figure 1). In the 
proton NMR spectrum of 3E and 3Z cycloadducts, the presence of the exocyclic double bond 
was justified clearly by two singlets at (7.72-7.75) (3E) and (7.01-7.07) ppm (3Z) 
characteristics of olefinic protons. The observed shielding of methyl group linked to N2 at 
(2.58-2.60) (3E) and (2.50-2.58) ppm (3Z) (instead of 3.50 ppm initially) permits to confirm 
the preferential attack site (C=S) of the addition of 1. On the other hand, in 13C NMR 
spectrum of the two stereoisomers, the chemical shifts of the carbon atoms at  (144.2-145.8) 
and (118.2-118.9) ppm for 3E and (144.5-146.0) and (117.6-118.4) ppm for 3Z assigned 
respectively to =CH and C6 exclude categorically the addition on the exocyclic double bond 
dipolarophile site. The reactive C=S site of the addition was confirmed again in this 
spectrum by the absence of thioxo group signal. The carbon chemical shifts at (97.2-98.5) 
and (98.2-98.6) ppm assigned respectively to spiranic carbons of 3E and 3Z are consistent 
with these structures. The proposed regiochemistry of the addition is in good agreement with 
that observed for other related systems.24 The nitrogen atom of the dipole is linked to the 
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carbon atom of dipolarophile site C=S. No condensation products of the dipole on the 
dipolarophile sites (C=C, C=N and C=O) has been observed. It is to note that while the 
extraction was made using a more polar solvent, as dichloromethane, the cycloadduct 3 was 
not isolated evolving directly the conversion to the compounds 4 and 5. 
For the isolated 1,2-pyrazol-1,3,4-thiadiazole 4d and 5e, the X-ray diffraction and 
spectral data are in accordance with the proposed structures (Scheme 1). Thus, the 
examination of NMR spectra and mass spectrum shows that these products are formed by 
monocycloaddition of nitrilimine on the double bond C=S. Then the corresponding 
cycloadducts are transformed into 4a-f and 5a-f compounds. In 1H NMR spectra of 4a-f 
compounds, we noted in particular the chemical shift of aldehyde proton at about (9.74-9.83) 
ppm. The =C-CH3 and N-CH3 protons resonate as singlet at (2.38-2.56) and (3.50-3.61) ppm 
respectively. Methyl and methylene of CO2Et group show triplet and quartet at about (1.32-
1.43) and (4.37-4.49) ppm respectively. In 13C NMR spectra of 4a-f the aldehyde carbonyl is 
confirmed again by the presence of the pick at (182.4-183.3) ppm. The signals of the carbon 
atoms C5 (151.4-153.0) ppm, C4’ (108.4-109.1) ppm, C5’ (149.8-151.3) ppm and C2 (160.5-
162.0) ppm confirm also the proposed structures. For compounds 5a-f, the presence of the 
olefinic protons is pointed out by a singlet at about (7.82-7.89) ppm. On the other hand, the 
13C NMR spectra reveal mainly the signals at (118.3-119.1), (135.1-136.7), (147.9-151.8), 
(151.9-156.3) and (163.4-164.9) ppm, attributed respectively to carbons C4’, C5’, C3’, C5, C2. 
To sum up, the 13DC reactions of 3-thioxo-[1,2,4]-triazepin-5-one 1 with the 
nitrilimines 2a-f are completely chemo and regioselective. In all cases the carbon atom of 
dipoles is linked to the sulphur atom of dipolarophile C=S site of 1. No addition of dipoles 
were observed on the C=N and C=O double bonds, and the exocyclic C=C double bond. 
However, along the purification of reaction mixture, the corresponding spirocycloadducts 
3a-f were quickly transformed into the bicycle compounds 4a-f and 5a-f. 
1.3. X-ray crystallography analysis. 
The molecular structures of 4d and 5e (C21H18N5OS, triclinic and C21H16ClN5OS, 
monoclinic) determined X-ray crystallography in this work are shown in Fig.1. The 
structures of 4d and 5e were obtained by slowly evaporating a benzene solution. Analysis of 
these X-ray structures allows to obtain some interesting features for the conversion of the 
spirocycloadducts 3a-f in the compounds 4a-f and 5a-f: i) the [1,2,4]triazepine ring is not 
present in these compounds, ii) the five-membered ring formed along the 13DC reaction 
remains in these structures, iii) the enamine substituent present in triazepine 1 is hydrolysed 
along these processes; iv) two new five-membered heterocycle compounds are formed along 
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the reaction; and v) these heterocycle compounds contain an α,β-unsaturated carbonyl 
group: one aldehyde on 4d and one ketone on 5e. 
 
4d 
 
5e 
Figure 1. The molecular structure of compound 4d and 5e (ORTEP: XTAL 3.6) with the 
numbering scheme. Displacement ellipsoids are drawn at 30% probability. 
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2. Theoretical results 
2.1. Study of the 1,3-dipolar cycloaddition reaction between 3-thioxo-[1,2,4]-triazepin-5-one 
1 and C-methoxycarbonyl-nitrilimine 2g. 
Firstly, the 13DC reaction between 3-thioxo-[1,2,4]-triazepin-5-one 1 and the C-
methoxycarbonyl-nitrilimine 2g, as a model of the nitrilimines a-c, was studied (see Scheme 
3). As it has been indicated in the experimental part, in spite of the presence of four 
dipolarophile sites in 1, these reactions take place with a total chemoselectivity; only the 
C=S double bond participates as dipolarophile in these 13DC reactions.22 According to the 
experimental result, we decided to perform the computational study of the addition of the 
nitrilimine 2g to the C=S double bond of 1. For this 13DC reaction, the two regioisomeric 
channels associated to the addition of 2g to the unsymmetric C=S double bond of 1 were 
studied. In addition, the E/Z configurational dispositions of the exocyclic C=C double bond 
present on 1 were also considered. An analysis of the stationary points found along the four 
reaction paths points out that these 13DC reactions have one-step mechanism. Thus, four 
TSs, TS1-E, TS1-Z, TS2-E, TS2-Z, and four [3+2] spirocycloadducts 3g-E, 3g-Z, 7g-E and 
7g-Z were located and characterized (see Scheme 3). The B3LYP/6-31G* total and relative 
energies are collected in Table 2. 
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Scheme 3 
The activation energies associated to the formation of the spirocycloadducts 3g-E and 
3g-Z, via TS1-E and TS1-Z, present very low values: 3.5 and 3.7 kcal/mol, respectively. The 
E/Z configuration of the exocyclic C=C double bond has not any appreciable incidence on 
the activation energies. These cycloadditions are strongly exothermic: –23.6 (3g-E) and –
23.2 (3g-Z) kcal/mol. On the other hand, formation of the regiosiomeric cycloadducts 7g-E 
and 7g-Z present very large activation energies: 21.0 (TS2-E) and 21.7 (TS2-Z) kcal/mol. 
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These energy results are in agreement with the complete regioselectivity experimentally 
observed. Formation of the regioisomeric cycloadducts are also less exothermic; –12.9 (7g-
E) and –15.1(7g-Z) kcal/mol. 
 
Table 2. Total (E, au) and relative (ΔE, kcal/mol) energies, in gas-phase and benzene, 
and total (G, au) and relative (ΔG, kcal/mol) free energies in benzene for stationary 
points involved in the 13DC reactions of 1-E and 1-Z with 2g.  
 
 gas-phase benzene 
 E  ΔE E  ΔE G  ΔG 
1-E –1043.772302  –1043.781561  –1043.598519 
1-Z –1043.772618  –1043.781063  –1043.597913 
2g –607.634412  –607.638885  –607.528673 
TS1-E –1651.401206 3.5 –1651.413185 4.6 –1651.100245 16.9
TS1-Z –1651.401206 3.7 –1651.412283 4.8 –1651.100349 16.8
3g-E –1651.444258 –23.6 –1651.454657 –21.5 –1651.134958 –4.9
3g-Z –1651.443973 –23.2 –1651.453334 –20.9 –1651.130806 –2.3
TS2-E –1651.373260  1.0 –1651.383731 23.0 –1651.068242 37.0
TS2-Z –1651.372481 21.7 –1651.382129 23.7 –1651.066401 37.8
7g-E –1651.427249 –12.9 –1651.435868 –9.7 -1651.118121 5.3
7g-Z –1651.431159 –15.1 –1651.438630 –11.7 –1651.119144 4.7
 
 
The geometries of the TSs involved in these 13DC reactions are depicted in Figure 2. 
At the more favourable regioisomeric TSs, TS1-E and TS1-Z, the length of the S1-C5 
forming bond is 2.408 and 2.407 Ǻ, while the distance between the C2 and the N3 atoms is 
3.288 and 3.321 Ǻ respectively. These values point out to very asynchronous bond-
formation processes in which the S1-C5 bond-formation is anticipated to the C2-N3 one. At 
the more unfavourable regioisomeric TSs, TS2-E and TS2-Z, the length of the C2-C5 
forming bond is 2.096 and 2.092 Ǻ, while the length of the S1-N3 bond is 2.482 and 2.482 
Ǻ, respectively. These TSs are more advanced and more synchronous. 
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Figure 2. Transition structures for the 13DC reactions of 3-thioxo-[1,2,4]-triazepin-5-one 1-
E and 1-Z with 2g. The values of the bond lengths are given in Ǻ. 
 
Analysis of the bond orders (BO) and the charge transfer (CT) at the TSs allows to 
establish the electronic nature of these 13DC reactions. At the more favourable 
regioisomeric TSs, TS1-E and TS1-Z, the BO values of the S1-C5 forming bond are 0.33 
and 0.34, while the BO values between the C2 and the N3 atoms are 0.03. These BO values 
indicate that only the S1-C5 bond is being formed at these asynchronous TSs. On the other 
hand, at the more unfavourable regioisomeric TSs, TS2-E and TS2-Z, the BO values of the 
C2-C5 and S1-N3 forming bonds are 0.43 and 0.30, respectively. These values point to 
concerted bond formation process where the C2-C5 bond formation is more advanced than 
the S1-N3 one.  
The CT at these cycloadditions was analyzed sharing the natural charges between the 
dipole and the dipolarophile fragments. At the more favourable regioisomeric TSs, the CT 
that fluxes from the 3-thioxo-[1,2,4]-triazepin-5-one 1 to the nitrilimine 2g is 0.26 e at both 
E/Z TSs. This large value indicates that these TSs have some zwitterionic character. On the 
other hand, at the more unfavourable regioisomeric TSs the CT is negligible, 0.05e, and it 
takes place in the opposite direction. This analysis indicates that the two regioisomeric 
cycloadditions are associated to unlike chemical processes. While the TSs associated to the 
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most favourable regioisomeric channels can be associated to two-center interactions between 
the most nucleophilic site of the 3-thioxo-[1,2,4]-triazepin-5-one 1, the sulphur S1 atom, and 
the most electrophilic site of nitrilimine 2g, the carbon C5 atom, the TSs associated to the 
more unfavourable regioisomeric channels can be related to four-center interactions 
characteristic of concerted cycloaddition processes. The flux of the CT found at the more 
favourable TSs is in agreement with the large electrophilic character of the nitrilimine 2g, ω 
= 1.75 eV, than that of 3-thioxo-[1,2,4]-triazepin-5-one 1-E, ω =1.30 eV.25  
As these cycloadditions have some polar character, and solvent can modify the 
energies, effect of benzene was considered. In benzene, all species are stabilized between 3 
and 8 kcal/mol. The more stabilized species are TS1-E and TS1-Z due to their polar 
character, 7.5 and 7.0 kcal/mol, respectively. However, the separated reagents become 
slightly more solvated. As a consequence, the activation energies increase in 1.1 kcal/mol. 
Solvent effects have not any incidence on the regioselectivity of the studied reaction. 
Finally, the inclusion of the thermal corrections and entropies to the total energies in 
benzene raises the free energies between 12 and 19 kcal/mol due to the bimolecular nature of 
these cycloadditions (see Table 2). The free activation energies associated TS1-E and TS1-Z 
are 16.9 and 16.8 kcal/mol. The regioisomeric TSs remains ca. 20 kcal/mol above the more 
favourable TSs. Finally, formation of the spirocycloadducts 3g-E and 3g-Z are slightly 
exergonic, –4.9 and –2.3 kcal/mol, respectively. 
 
2.2. Study of conversion of spirocycloadducts 3a-f into bicycloderivatives 4a-f and 5a-f. 
The spirocycloadducts 3a-f are very unstable, and they are converted quickly into the 
two bicyclo compounds 4a-f and 5a-f (see Scheme 1). Therefore, we have considered to 
study these conversions. Based on these observations obtained from the X-ray 
crystallography analysis of the compounds of 4d and 5e (see section 1-3) we have proposed 
a mechanism for the conversions that considers all structural changes (see Scheme 4). In a 
first step, the triazepine ring is opened by a N1-C2 breaking bond process to give the 
intermediate 8. Then, the enamine substituent present in 8 is hydrolysed to the corresponding 
aldehyde, yielding the dicarbonylic intermediate 9. Note that the ring cleavage and the 
enamine hydrolysis are independent. However, due to the large instability of these 
spirocompounds in an acid medium (see later) we assume that the ring cleavage takes place 
firstly. After the enamine hydrolysis, the two carbonyl groups on 9 can experiment an 
intramolecular condensation reaction with the terminal amine N1 atom. Formation of the 
new N-C bond via the intramolecular nucleophilic attack of the amine to each carbonyl 
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group present on 9 allows the formation of the two new five-membered heterocycles. 
Finally, a water elimination process on the bicyclic intermediates 10 and 11 allows the 
formation of 4g and 5g. 
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Scheme 4 
 
Due to the complexity of this mechanism, we decided to study the two more significant 
elementary steps (see A and B in Scheme 4). They include the ring cleavage of the triazepine 
ring, step A, and the ring closure of the dicarbonylic intermediate 9 with formation of the 
new bicyclic intermediates 10 and 11, step B. Note that hydrolysis of enamines and 
condensation reactions of carbonyl compounds with amines are common reactions in the 
chemistry of the carbonyl group. In addition, due to that the thiazole ring does not participate 
in the domino reaction, the methoxycarbonyl and phenyl groups present in the thiazole ring 
have been replaced by two hydrogen atoms in order to work with a more reduced model. 
 
All steps of the proposed mechanism need an acid catalysis in order to facilitate the 
breaking- and forming-bond processes associated to each elementary process (see Scheme 
5). After the protonation of the N1 nitrogen atom of the triazepinone ring of the 
spirocycloadduct 3, the activation energy associated to the N1-C2 breaking-bond of the 
intermediate IN1 via TS3, is only of 2.6 kcal/mol. This ring cleavage process is very 
exothermic, –23.9 kcal/mol. These energy results indicate that in acid environment the 
spirocycloadducts 3a-f are kinetically and thermodynamically very unstable, yielding 
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irreversibly the open intermediates as 8 (see Scheme 4). Note that the N1 nitrogen atom of 
these spirocycloadducts corresponds to the most basic center of these molecules. 
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Scheme 5 
 
For the ring-closure step with formation of the five-membered heterocycles present in 
4g and 5g, we found a unique TS4 followed by a downhill intrinsic reaction coordinate until 
the path bifurcates into two equivalent downhill pathways allowing the formation of the 
intermediate IN4, result of the nucleophilic attack of the amine N1 nitrogen atom to the 
ketone C3 carbon atom, and the intermediate IN5, result of the attack of this nitrogen atom 
to the aldehyde C7 carbon atom. This TS is located only 1.1 kcal/mol above the intermediate 
IN3. Formation of the intermediates IN4 and IN5 is exothermic in –1.8 and –24.7 kcal/mol, 
respectively. The low exothermic character of IN4 can be related to the loss of the 
conjugation associated to the nucleophilic attack to the ketone group. Spite of the low 
exothermic character of formation of the intermediate IN4, the quick exchange of the N1 
proton by an acid/base process can turn irreversible this step after water elimination. Full 
optimisation of the stationary points associated to the paths A and B at the B3LYP/6-31+G* 
does not produce appreciable changes (see Table 3). Only the relative energy of TS4 
increases to 10.5 kcal/mol. 
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Table 3. Total (E, au) and relative (ΔE, kcal/mol) energies, in gas-phase and 
dichloromethane, and total (G, au) and relative (ΔG, kcal/mol) free energies in 
dichloromethane, for the more relevant stationary points corresponding to the reaction model 
for transformation of spirocycloadduct 3g to 4g and 5g products. 
 
 B3LYP/6-31G* B3LYP/6-31+G* B3LYP/6-31G* 
 gas-phase dichloromethane 
 E ΔE E ΔE E ΔE G ΔG 
IN1 –1192.905939  –1192.928240 –1192.977586  –1192.75108
TS3 –1192.901739 2.6 –1192.924370 2.4 –1192.974637 1.9 –1192.74961 0.9
IN2 –1192.944099 –23.9 –1192.965038 –23.1 –1193.011543 –21.3 –1192.78486 –21.2
IN3 –1134.158984  –1134.180397 –1134.236299  –1134.07706
TS4 –1134.157262 1.1 –1134.163718 10.5 –1134.234001 1.4 –1134.07179 3.3
IN4 –1134.161908 –1.8 –1134.183691 -2.1 –1134.238627 –1.5 –1134.07442 1.7
IN5 –1134.198415 –24.7 –1134.220647 –25.3 –1134.274285 –23.8 –1134.10736 –19.0
 
The geometries of TS3 and TS4 are given in Figure 3. At TS3, the length of the N1-C2 
breaking bond is 2.138 Å, while the BO value is 0.31. At TS4, the distance between the 
amine N1 nitrogen atom and the aldehyde carbonyl C7 carbon atom and the ketone carbonyl 
C3 carbon atom is 2.909 and 2.787 Å, respectively. These large distances point out the early 
character of this TS. 
TS3
TS4
2.138
2.909 2.787
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Figure 3. Transition structures involved in the reaction model for the transformation of 
spirocycloadduct 3g to 4g and 5g products. 
 
At the intermediate IN3 the protonation takes place at the most basic ketone O7 
oxygen atom, but the proton forms also a strong hydrogen bond with the aldehyde O9 
oxygen atom, with a bond length of 1.615 Å. This behaviour remains also at TS4. The IRC 
from TS4 to IN4 shows that along the nucleophilic attack of the amine N1 nitrogen atom to 
the aldehyde C7 carbon atom, the proton moves from the ketone O7 oxygen atom to the 
aldehyde O9 oxygen atom, thus stabilising the negative charge that develops at the aldehyde 
O9 oxygen atom along the nucleophilic attack to the C8 carbon atom. The same mechanism, 
related to the synthesis of pyrazoles reaction of hydrazines with beta-dicarbonyl compounds, 
has been studied by Elguero and coworkers.26  
Dichloromethane stabilises all structures between 42 – 49 kcal/mol, as a consequence 
of the cationic character of this species. However, the inclusion of solvent effect does not 
modify the gas-phase relative energies. Finally, the inclusion of the thermal corrections and 
entropies to the total energies in dichloromethane causes minor changes on the relative free 
energies associated to this domino process due to the intramolecular nature of the two 
elementary steps. The activation free energies for the two elementary steps present very low 
values, 0.9 kcal/mol (TS3) and 3.3  kcal/mol (TS4) (see Table 3). These values support the 
feasibility of these steps. On the other hand, formation of the intermediate IN2 is a strongly 
exergonic process, –21.2 kcal/mol. Therefore, in an acid medium, the spirocycloadducts as 
3g are kinetically and thermodynamically very unstable in clear agreement with the 
experimental outcome.  
In conclusion, both energy results and geometries associated to the A and B elementary 
steps studied in Scheme 5 support the mechanism proposed in Scheme 4 for the 
transformation of the spirocycloadduct 3g into the bicyclo compounds 4g and 5g. Note that 
for the other non-studied elementary steps of Scheme 4, it is assumed that they take place 
easily.  
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CONCLUSION  
New bicyclic pyrazol-1,3,4-thiadiazole derivatives 4a-f and 5a-f have been synthesized by 
reaction between  the 3-thioxo-[1,2,4]-triazepin-5-one 1 and several nitrilimines 2a-f. The 
studied reactions take place through two reaction types: a 13DC reaction between 1 and 2a-f, 
and a domino reaction allowing the conversion of the corresponding spirocycloadducts 3a-f 
into the final bicyclic compounds 4a-f and 5a-f, which were characterized by NMR and X-
ray analyses. The mechanism of the two reaction types have been theoretically studied using 
DFT calculations at the B3LYP/6-31G(d) level. The spirocycloaduct 3g is obtained through 
a 13DC reaction via a high asynchronous mechanism with a very low activation energy. The 
computational results support the total regioselectivity experimentally observed. For the 
conversion of the spirocycloadducts 3a-f into the two biciclyc compounds 4a-f and 5a-f, a 
domino reaction that comprises the cleavage of the triazepin ring, hydrolysis of the enamine 
substituent, and two intramolecular condensation reactions to form the two new five-
membered heterocycles has been proposed. The elementary steps responsible for the N2-C3 
cleavage of the triazepin ring and the intramolecular nucleophilic addition reaction to the 
carbonyl groups to yield the thiazolo and diazolo rings have been studied. The energy results 
obtained for these elementary steps support the suitability of the proposed mechanism, 
allowing to explain formation of the two bicyclic pyrazol-1,3,4-thiadiazole derivatives. 
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COMPUTATIONAL METHODS 
Quantum chemical calculations were performed with the use of the Gaussian 03 set of 
programs.27 All structures were fully optimized with the density functional theory (DFT) 
using Becke’s three parameter hybrid method 28 and correlation functional of Lee-Yang-Parr 
(B3LYP) 29 in conjunction with the 6-31G* and 6-31+G*30 basis sets. The stationary points 
were characterized by harmonic vibrational frequency analysis in order to verify that minima 
and transition structures have zero and one imaginary frequency, respectively. Starting from a 
transition structures, the intrinsic reaction coordinate (IRC)31 pathway has also been 
constructed in order to verify further its identity and also map out a minimum energy reaction 
pathway. Net atomic charges of the stationary points were obtained by using the natural bond 
orbital (NBO) approach.32 The solvent effects have been considered by B3LYP/6-31G* 
single point calculations over the gas phase optimized structures using a self-consistent 
reaction field 33 (SCRF) based on the PCM method of the Tomasi’s group.34 Since these 
reactions are carried out in benzene and dichloromethane, we have selected its dielectric 
constants at 298.0 K.  The values of the free energies in benzene and dichloromethane were 
calculated with the standard statistical thermodynamics at 298.15 K and 1 atm.30 
Thermodynamic calculations were scaled by a factor of 0.96. 
 
EXPERIMENTAL SECTION 
 
Melting points were taken on a Buchi 510 apparatus and were uncorrected. The 1H NMR 
spectra were recorded with the following instruments: Bruker WP 400 CW and AC 250. 
TMS was used as an internal reference. The 13C NMR spectra were measured on a Varian 
FT 80 (20.0 MHz). Mass spectra were recorded with a JEOL JMS DX 300. Column 
chromatography was carried out using E-Merck silica gel 60F254. Reagents and solvents 
were purified in the usual Way. The data collections of X-ray structures were performed at 
293º K on a Nonius Kappa-CCD single crystal diffractometer, using Mo Kαradiation 
( λ=0.7173 Å). Crystal-detector distance was fixed at 35 mm, and a total of 220/ 325 images 
were collected using the oscillation method, with scan angle per frame 2º oscillation and 20s. 
exposure time per image. Data collection strategy was calculated with the program Collect.35 
Data reduction and cell refinements were performed with the programs HKL Denzo and 
Scalepack.36 The crystal structure was solved by direct Methods, using the program SIR-97.37 
Anisotropic least-squares refinement was carried out with SHELXL-97.38 All non hydrogen 
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atoms were anisotropically refined. Some Hydrogen atoms were located in a difference 
Fourier maps and the remaining ones located geometrically. Geometrical calculations were 
made with PARST.39 The crystallographic plots were made with Mercury.40 
Synthesis of [1,2,4]triazepine 1 
A solution of 3-thioxo[1,2,4]triazepin-5-one 6 (5.8mmol.) and dimethyl 
formamidedimethyl acetal (DMF-DMA) (20 ml) was stirred for 1h at 5°C. The precipitated 
solid was filtered off under reduced pressure and the crude solid subjected to silica-gel using 
80/20 % ethyl acetate/hexane mixture as eluent gave a 66:34 mixture of two isomers 1E and 
1Z in good yield 65%.  
 
(E)-6-(dimethylaminomethylene)-2,7-dimethyl-3-thioxo-3,4,5,6-tetrahydro-2H-[1,2,4] 
triazepin-5-one 1E.  
Percentage: 66, 1H NMR (CDCl3): δppm: 2.08 (s, 3H, C7-CH3), 3.07 (s, 6H, N(CH3)2), 3.57 
(s, 3H, N2-CH3), 7.55 (s,1H, H-C=), 7.84 (s,1H, NH). 13C NMR (CDCl3): δppm: (C7-CH3), 
44.95 (N-(CH3)2), 45.3 (N2-CH3), 154.5 (H-C=), 96.1 (C6), 164.2 (C7), 168.2 (C5), 177.4 
(C3), Mass spectrum (FAB) m/z : 475 [M+H]+ 
 
(Z)-6-(dimethylaminomethylene)-2,7-dimethyl-3-thioxo-3,4,5,6-tetrahydro-2H-[1,2,4] 
triazepin-5-one 1Z.  
Percentage: 34, 1H NMR (CDCl3): δppm: 2.18 (s, 3H, C7-CH3), 3.07 (s, 6H, N(CH3)2), 
3.50(s, 3H, N2-CH3), 7.05 (s, 1H, H-C=), 7.90 (s, 1H, NH). 13C NMR (CDCl3): δppm: 22.0 
(C7-CH3), 44.9 (N-(CH3)2), 44.7 (N2-CH3), 154.1 (H-C=), 96.5 (C6), 163.6 (C7), 164.9 (C5), 
177.2 (C3), Mass spectrum (FAB) m/z: 475 [M+H]+ 
 
General procedure for preparation of products 3a-c, 4a-c and 5a-c 
To a solution of 1,2,4-triazepine 1 (5mmol) and ethylhydrazono-α-bromoglyoxylate 
(5.5mmol) in dry benzene (30ml), triethylamine (7.2mmol) dissolved in dry benzene (10ml) 
was added dropwise. After stirring for 72 hours at room temperature, the solvent was then 
removed under vacuum and the mixture was diluted with water (25ml) and extracted with 
dichloromethane (3X50ml). The organic layers were dried over  anhydrous sodium sulphate, 
concentrated under reduced pressure and the yellow crystalline product thus obtained 3a-c 
was further transformed to pure 4a-c and 5a-c compounds by chromatography on a silica gel 
column (eluent:hexane/ethylacetate,75/25). 
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Ethyl (6E)-(2,7-dimethyl-5-oxo-6-((dimethylamino)methylene)-3,4,5,6-tetrahydro-2H-
[1,2,4]triazepine-3-spiro-2’-(3’-(p-tolyl)-2’,3’-dihydro[1,3,4]thiadiazole-5’-carboxylate 
3a.  
1H NMR (CDCl3): δ ppm: 1.26-1.30 (m, 3H, COOCH2CH3), 2.04 (s, 3H, C7-CH3), 2.60 (s, 
3H, N2-CH3), 3.10 (s, 6H, N(CH3)2), 4.22-4.33 (m, 2H, -CH2-O), 7.75 (s, 1H, C6=CH), 6.40 
(s, 1H, NH), 6.92 (d, 2H, J=9.31Hz, H-Ar), 7.36 (d, 2H, J=9.31Hz, H-Ar). 13C NMR 
(CDCl3): δ ppm: 14.4 (COOCH2CH3), 14.7 (C7-CH3), 24.7 (N2-CH3), 40.7 (N(CH3)2), 62.8 
(-CH2-O), 98.5 (C2’), 118.2 (C6), 117.4, 129.7 (CHAr), 134.4, 135.6 (CAr), 144.9 (C6=CH), 
154.5 (C7), 160.4 (C5’), 165.6 (C=OC2H5), 169.2 (C5). 
 
Ethyl (6Z)-(2,7-dimethyl-5-oxo-6-((dimethylamino)methylene)-3,4,5,6-tetrahydro-2H 
[1,2,4]triazepine-3-spiro-2’-(3’-(p-tolyl)-2’,3’-dihydro[1,3,4]thiadiazole-5’-carboxylate 
3a.  
1H NMR (CDCl3): δ ppm: 1.26-1.30 (m, 3H, COOCH2CH3), 1.99 (s, 3H, C7-CH3), 2.50 (s, 
3H, N2-CH3), 3.10 (s, 6H, N(CH3)2), 4.22-4.33 (m, 2H, -CH2-O), 7.02 (s, 1H, C6=CH), 6.87 
(s,1H, NH), 6.87 (d, 2H, J=9.31Hz, H-Ar), 7.30 (d, 2H, J=9.31Hz, H-Ar). 13C NMR 
(CDCl3): δ ppm: 14.3 (COOCH2CH3), 14.4 (C7-CH3), 21.4 (N2-CH3), 41.1 (N(CH3)2), 63.5 
(-CH2-O), 98.2 (C2’), 117.6 (C6); 117.2, 129.3 (CHAr); 134.5, 135.1 (CAr), 145.1 (C6=CH), 
155.3 (C7), 162.0 (C5’), 165.7 (C=OC2H5), 169.3 (C5). 
 
Ethyl (6E)-(2,7-dimethyl-5-oxo-6-((dimethylamino)methylene)-3,4,5,6-tetrahydro-2H 
[1,2,4]triazepine-3-spiro-2’-(3’-(p-chlorophenyl)-2’,3’-dihydro[1,3,4]thiadiazole-5’-
carboxylate 3b.  
1H NMR (CDCl3): δ ppm: 1.35-1.37 (m, 3H, COOCH2CH3), 2.07 (s, 3H, C7-CH3), 2.58 (s, 
3H, N2-CH3), 3.14 (s, 6H, N(CH3)2), 4.28-4.37 (m, 2H, -CH2-O), 7.72 (s, 1H, C6=CH), 6.40 
(s,1H, NH), 7.10 (d, 2H, J=9.31Hz, H-Ar), 7.93 (d, 2H, J=9.31Hz, H-Ar). 13C NMR 
(CDCl3): δ ppm: 14.4 (COOCH2CH3), 14.6 (C7-CH3), 24.6, (N2-CH3), 40.3 (N(CH3)2), 62.8 
(-CH2-O), 97.2 (C2’), 118.9 (C6), 121.3, 125.5 (CHAr), 130.4, 136.6 (CAr), 144.2 (C6=CH), 
152.8 (C7), 159.3 (C5’), 165.8 (C=OC2H5), 169.8 (C5). 
 
Ethyl (6Z)-(2,7-dimethyl-5-oxo-6-((dimethylamino)methylene)-3,4,5,6-tetrahydro-2H 
[1,2,4]triazepine-3-spiro-2’-(3’-(p-chlorophenyl)-2’,3’-dihydro[1,3,4]thiadiazole-5’-
carboxylate 3b.  
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1H NMR (CDCl3): δ ppm: 1.35-1.37 (m, 3H, COOCH2CH3), 2.00 (s, 3H, C7-CH3), 2.56 (s, 
3H, N2-CH3), 3.14 (s, 6H, N(CH3)2), 4.28-4.37 (m, 2H, -CH2-O), 7.01 (s, 1H, C6=CH), 6.73 
(s,1H, NH), 7.13 (d, 2H, J=9.31Hz, H-Ar), 7.87 (d, 2H, J=9.31Hz, H-Ar). 13C NMR 
(CDCl3): δ ppm: 14.2 (COOCH2CH3), 14.3 (C7-CH3); 21.8, (N2-CH3), 40.8 (N(CH3)2), 63.6 
(-CH2-O), 98.3 (C2’); 118.4 (C6), 121.1, 125.0 (CHAr), 130.5, 137.2 (CAr), 144.5 (C6=CH), 
153.7 (C7); 160.0 (C5’), 165.6 (C=OC2H5), 169.9 (C5). 
 
Ethyl (6E)-(2,7-dimethyl-5-oxo-6-((dimethylamino)methylene)-3,4,5,6-tetrahydro-2H 
[1,2,4]triazepine-3-spiro-2’-(3’-(p-nitrophenyl)-2’,3’-dihydro[1,3,4]thiadiazole-5’-
carboxylate 3c.  
1H NMR (CDCl3): δ ppm: 1.36-1.39 (m, 3H, COOCH2CH3), 2.08 (s, 3H, C7-CH3), 2.60 (s, 
3H, N2-CH3), 3.15 (s, 6H, N(CH3)2), 4.31-4.41 (m, 2H, -CH2-O), 7.75 (s, 1H, C6=CH), 6.45 
(s, 1H, NH), 7.79 (d, 2H, J=9.35Hz, H-Ar), 8.11 (d, 2H, J=9.35Hz, H-Ar). 13C NMR 
(CDCl3): δ ppm: 14.5 (COOCH2CH3), 14.6 (C7-CH3), 24.6, (N2’-CH3), 40.4 (N(CH3)2), 63.0 
(-CH2-O), 97.9 (C2’), 118.6 (C6), 118.3, 125.3 (CHAr), 138.4, 143.4 (CAr), 145.8 (C6=CH), 
153.9 (C7), 160.1 (C5’), 165.7 (C=OC2H5), 169.7 (C5). 
 
Ethyl (6Z)-(2,7-dimethyl-5-oxo-6-((dimethylamino)methylene)-3,4,5,6-tetrahydro-2H 
[1,2,4]triazepine-3-spiro-2’-(3’-(p-nitrophenyl)-2’,3’-dihydro[1,3,4]thiadiazole-5’-
carboxylate 3c.  
1H NMR (CDCl3): δ ppm: 1.36-1.39 (m, 3H, COOCH2CH3), 2.00 (s, 3H, C7-CH3), 2.58 (s, 
3H, N2-CH3), 3.15 (s, 6H, N(CH3)2), 4.31-4.41 (m, 2H, -CH2-O), 7.07 (s, 1H, C6=CH), 6.76 
(s,1H, NH), 7.81 (d, 2H, J=9.33Hz, H-Ar), 8.05 (d, 2H, J=9.331Hz, H-Ar). 13C NMR 
(CDCl3): δ ppm: 14.3 (COOCH2CH3) 14.4 (C7-CH3), 21.3 (N2-CH3), 40.9 (N(CH3)2), 63.9 (-
CH2-O), 98.6 (C2’), 118.1 (C6), 118.2, 124.8 (CHAr), 138.5, 144.0 (CAr), 146.0 (C6=CH), 
154.7 (C7), 161.8 (C5’), 165.8 (C=OC2H5), 169.8 (C5). 
 
Ethyl (E)-2-(4’-formyl-1’,3’-dimethyl-1H-[1,2]pyrazol-5’-ylimino)-3-p-tolyl-2,3-dihydro 
[1,3,4]thiadiazole-5-carboxylate 4a.  
mp: 151-152°C (EtOH). 1H NMR (CDCl3): δppm: 1.32 (t, 3H, J=7.19 Hz,-CH2-CH3), 2.33 
(s, 3H, Ar-CH3), 2.38 (s, 3H, C3’-CH3), 3.50 (s, 3H, N1’-CH3), 4.37 (q, 2H, J=7.19Hz, -O-
CH2-), 7.21, 7.67 (2d, J=9.25Hz, 4H, HAr), 9.74 (s, 1H, CHO). 13C NMR (CDCl3): δppm: 
13.4 (COOCH2CH3), 14.5 (C3’-CH3), 21.5 (Ar-CH3), 34.8 (N1’-CH3), 63.6 (O-CH2), 108.8 
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(C4’), 124.5, 129.9, 135.8, 138.9 (CAr), 141.5 (C3’), 151.3, 151.4 (C5’, C5), 158.1 (CO2Et), 
162.0 (C2), 183.0 (CHO). Mass spectrum (FAB): m/z 386 [M+H]+ 100%. 
  
Ethyl (E)-2-(1’,3’-dimethyl-1H-[1,2]pyrazol-4’-ylcarbonylimino)-3-p-tolyl-2,3-dihydro 
[1,3,4]thiadiazole-5-carboxylate 5a.  
mp: 183-184°C (EtOH). 1H NMR (CDCl3): δppm: 1.44 (t, 3H, J=7.14 Hz,-CH2-CH3), 2.45, 
2.50 (2s, 6H, Ar-CH3, C3’-CH3), 3.83 (s, 3H, N1’-CH3), 4.49 (q, 2H, J=7.14Hz, -O-CH2-), 
7.33, 7.75 (2d, J= 9.19Hz, 4H, HAr), 7.84 (s, 1H, C5’-H). 13C NMR (CDCll3): δppm: 14.3, 
14.5 (COOCH2CH3 and C3’-CH3), 21.6 (Ar-CH3), 39.3 (N1’-CH3), 63.5 (O-CH2-), 118.9 
(C4’), 125.4, 129.8, 135.7, 139.2 (CAr), 136.7 (C5’), 147.9, 151.9 (C3’, C5), 159.0, 164.9 
(CO2Et, C2), 171.8 (CO). Mass spectrum (FAB): m/z 386 [M+H]+ 100%. 
 
Ethyl (E)-2-(4’-formyl-1’,3’-dimethyl-1H-[1,2]pyrazol-5’-ylimino)-3-p-chlorophenyl-
2,3-dihydro[1,3,4]thiadiazole-5-carboxylate 4b.  
mp: 158-159°C (EtOH). 1H NMR (CDCl3): δppm: 1.42 (t, 3H, J=7.18 Hz, -CH2-CH3), 2.48 
(s, 3H, C3’-CH3), 3.60 (s, 3H, N1’-CH3), 4.45 (q, 2H, J=7.18 Hz, -O-CH2-), 7.49- 7.87 (2d, 
J=9.24Hz, 4H, HAr), 9.80 (s, 1H, CHO). 13C NMR (CDCl3): δppm: 13.3 (COOC2H5), 14.5 
(C3’-CH3), 34.9 (N1’-CH3), 63.9 (O-CH2), 109.1 (C4’), 125.6, 126.5, 134.3, 136.8 (CAr), 
142.3 (C3’), 150.7, 151.4 (C5’,C5), 158.0 (CO2Et), 161.7 (C2), 183.2 (CHO). Mass spectrum 
(FAB): m/z 406 [M+H]+ 100%. 
 
Ethyl (E)-2-(1’,3’-dimethyl-1H-[1,2]pyrazol-4’-ylcarbonylimino)-4-p-chlorophenyl-2,3-
dihydro[1,3,4]thiadiazole-5-carboxylate 5b.  
mp: 199-200°C (EtOH). 1H NMR (CDCl3): δppm: 1.47 (t, 3H, J=7.13Hz, -CH2-CH3), 2.54 
(s, 3H, C3’-CH3), 3.88 (s, 3H, N1’-CH3), 4.52 (q, 2H, J=7.13Hz, -O-CH2-), 7.55-7.90 (2d, 
J=9.18Hz, 4H, HAr), 7.86 (s, 1H, C5’-H). 13C NMR (CDCl3): δppm: 14.3, 14.6 
(COOCH2CH3 and C3’-CH3), 39.4 (N1’-CH3), 63.7 (O-CH2-), 118.7 (C4’), 126.5, 129.4, 
134.8, 137.6 (CAr), 135.7 (C5’), 148.4, 151.9 (C3’, C5), 158.8, 164.8 (CO2Et, C2), 171.7 
(CO). Mass spectrum (FAB): m/z 406 [M+H]+ 100%. 
 
Ethyl (E)-2-(4’-formyl-1’,3’-dimethyl-1H-[1,2]pyrazol-5’-ylimino)- 3-p-nitrophenyl-2,3-
dihydro[1,3,4]thiadiazole-5-carboxylate 4c.  
mp: 167-169°C (EtOH). 1H NMR (CDCl3): δppm: 1.43 (t, 3H, J=7.21Hz, -CH2-CH3), 2.48 
(s, 3H, C3’-CH3), 3.61 (s, 3H, N1’-CH3), 4.49 (q, 2H, J=7.21Hz, -O-CH2-), 8.28-8.36 (2m, 
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4H, HAr), 9.83 (s, 1H, CHO). 13C NMR (CDCl3): δppm: 13.2 (COOCH2CH3), 14.5 (C3’-
CH3), 35.0 (N1’-CH3), 64.1 (-O-CH2), 109.3 (C4’), 123.8, 124.9, 143.4, 146.6 (CAr), 143.6 
(C3’), 149.8, 151.9 (C5’, C5), 157.7 (CO2Et), 161.3 (C2), 183.3 (CHO). Mass spectrum 
(FAB): m/z 417 [M+H]+ 100%.  
 
Ethyl (E)-2-(1’,3’-dimethyl-1H-[1,2]pyrazole-4’-carbonylimino)-3-p-nitro-phenyl-2,3-
dihydro[1,3,4]thiadiazole-5-carboxylate  5c.  
mp: 213-214°C (EtOH). 1H NMR (CDCl3): δppm: 1.47 (t, 3H, J=7.17Hz, -CH2-CH3), 2.54 
(s, 3H, C3’-CH3), 3.88 (s, 3H, N1’-CH3), 4.53 (q, 2H, J=7.17Hz, -O-CH2-), 8.36-8.44 (2m, 
4H, HAr), 7.89 (s, 1H, C5’-H). 13C NMR (CDCl3): δppm: 14.3, 14.5 (COOCH2CH3) and 
C3’-CH3), 39.4 (N1’-CH3), 63.9 (O-CH2-), 118.3 (C4’), 124.8, 125.2, 143.9, 147.0 (CAr), 
135.7 (C5’), 149.3, 152.2 (C3’, C5), 158.6, 164.7 (CO2Et, C2), 171.5 (CO). Mass spectrum 
(FAB): m/z 417 [M+H]+ 100%. 
General procedure for preparation of products 3d-f, 4d-f and 5d-f 
To a solution of 5mmol. of dimethylaminomethylene-3-thioxo-1,2,4-triazepin-5-one 
1 and 5mmol. of α-chloroarylidenephenylhydrazone in 20ml of dry benzene, was added 
1.6ml of dry triethylamine dissolved in dry benzene. After stirring for 72 hours at room 
temperature, the reaction mixture was extracted with benzene (3x50ml) and the organic 
layers were dried over anhydrous sodium sulphate and evaporated under reduced pressure. 
The yellow crude solid thus obtained 3d-f were further transformed to pure 4d-f and 5d-f 
compounds by chromatography on a silica gel column using ethyl acetate/ hexane as eluent.  
 
 (E)-2-(4’-formyl-1’,3’-dimethyl-1H-[1,2]pyrazol-5’-ylimino)-5-p-tolyl-3-phenyl-2,3-
dihydro[1,3,4]thiadiazole 4d 
mp: 141-142°C (EtOH). 1H NMR (CDCl3): δ (ppm): 2.39 (1s, 3H, Ar-CH3), 2.46 (s, 3H, C3’-
CH3), 3.60 (s, 3H, N1’-CH3), 7.23-8.01 (m, 9H, HAr), 9.80 (s, 1H, CHO). 13C NMR 
(CDCl3): δ (ppm): 13.5 (C3’-CH3), 21.5 (Ar-CH3), 34.4 (N1’-CH3), 108.4 (C4’), 123.4, 126.2, 
127.4, 128.9, 129.8 (5 CH-Ar), 126.8, 138.8, 141.7 (3 CAr), 149.6, 150.7, 153.0 (C3’, C5’, 
C5), 161.2 (C2), 183.0 (CHO). 
Mass spectrum, (m/z): 389 [M] + (100%), 208, 91. 
 
 (E)-2-(1’,3’-dimethyl-1H-[1,2]pyrazol-4’-ylcarbonylimino)-3-p-tolyl-5-phenyl-2,3-
dihydro-[1,3,4]thiadiazole 5d.  
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mp: 175-176°C (EtOH). 1H NMR (CDCl3): δ (ppm): 2.16 (1s, 3H, Ar-CH3), 2.41 (s, 3H, C3’-
CH3), 3.83 (s, 3H, N1’-CH3), 7.86 (s, 1H, C5’-H), 7.26-8.00 (m, 9H, HAr).  13C NMR 
(CDCl3): δ (ppm): 13.9 (C3’-CH3), 21.5 (Ar-CH3), 38.9 (N1’-CH3), 118.9 (C4’), 124.7, 126.5, 
127.9, 128.7, 129.9 (5 CH-Ar), 127.2, 139.3, 141.6 (3 CAr), 135.1 (C5’), 151.3, 156.3 (C3’, 
C5), 163.5 (C2), 171.3 (CO). 
Mass spectrum, (m/z): 389 [M]+ 123(100%), 280, 208, 91. 
 
(E)-2-(4’-formyl-1’,3’-dimethyl-1H-[1,2]pyrazol-5’-ylimino)-3-p-chlorophenyl-5-phenyl-
2,3-dihydro[1,3,4]thiadiazole 4e 
mp: 165-166°C (EtOH). 1H NMR (CDCl3): δ(ppm): 2.55 (1s, 3H, C3’-CH3), 3.60 (1s, 3H, 
N1’-CH3), 7.35-8.00 (m, 9H, HAr),  9.82 (s, 1H, CHO). RMN 13C NMR (CDCl3): 13.8 (C3’-
CH3), 34.8 (N1’-CH3), 108.9 (C4’), 123.9, 127.9, 128.0, 129.4, 129.8 (5CH-Ar), 128.5, 137.7, 
139.0 (3 CAr), 148.7, 151.3, 152.8, 161.2 (C3’, C5’, C5, C2 ),  183.3 (CHO). 
Mass spectrum, (m/z): 409 [M]+, 389, 91(100%). 
 
(E)-2-(1’,3’-dimethyl-1H-[1,2]pyrazol-4’-ylcarbonylimino)-5-p-chlorophenyl-3-phenyl-
2,3-dihydro[1,3,4]thiadiazole 5e.  
mp: 195-196°C (ETOH). 1H NMR (CDCl3): δ (ppm):  2.52 (s, 3H, C3’-CH3), 3.84 (s, 3H, 
N1’- CH3), 7.82 (s, 1H, C5’-H), 7.26-7.99 (m, 9H, HAr).  13C NMR (CDCl3): δ (ppm): 14.3 
(C3’-CH3), 39.3 (N1’-CH3), 119.1 (C4’), 125.0, 128.2, 128.5, 129.2, 129.9 (5 CH-Ar), 128.9, 
137.7, 139.6 (3 CAr), 135.6 (C5’), 151.8, 155.1 (C3’, C5), 163.7 (C2), 171.7 (CO). 
Mass spectrum, (m/z): 409 [M]+, 300, 123(100%), 91. 
 
(E)-2-(4’-formyl-1’,3’-dimethyl-1H-[1,2]pyrazol-5’-ylimino)-2,3-dihydro-5-p-nitro- 
phenyl-3-phenyl[1,3,4]thiadiazole 4f 
mp : 144-146°C (EtOH). 1H NMR (CDCl3): δ (ppm): 2.48 (s, 3H, C3’-CH3), 3.61 (s, 3H, N1’-
CH3), 7.26-8.33 (m, 9H, HAr), 9.83 (s, 1H, CHO). 13C NMR (CDCl3): δ (ppm): 13.2 (C3’-
CH3), 34.5 (N1’-CH3), 108.6 (C4’) 123.7, 124.4, 127.0, 128.0, 129.1 (5 CH-Ar), 135.2, 138.3, 
147.0 (3 CAr); 149.0 (C3’), 151.1, 151.4 (C5’, C5), 160.5 (C2), 182.4 (CHO). 
Mass spectrum, (m/z): 420 [M] +, 123 (100%), 91. 
 
 (E)-2-(1’,3’-dimethyl-1H-[1,2]pyrazol-4’-ylcarbonylimino)-3-p-nitrophenyl-5-phenyl-
2,3-dihydro[1,3,4]thiadiazole 5f.  
 23
mp: 210-211°C (EtOH). 1H NMR (CDCl3): δ (ppm): 2.53 (s, 3H, C3’-CH3), 3.85 (s, 3H, N1’-
CH3), 7.88 (s, 1H, C5’-H), 7.26-8.38 (m, 9H, HAr). 13C NMR (CDCl3): δ (ppm): 13.9 (C3’-
CH3), 39.0 (N1’-CH3), 118.5 (C4’), 124.5, 124.7, 127.3, 128.4, 128.9 (5 CH-Ar), 135.8, 139.0, 
149.0 (3 CAr), 135.3 (C5’), 151.5, 153.4 (C3’, C5), 163.4 (C2), 171.4 (C=O). 
Mass spectrum, (m/z): 420 [M] + (100%), 91. 
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